Pharmacotherapy

February 26, 2024

FAQs on Pantovigar: Can We Use it For Renal Patients?

The ingredients listed in the PANTOVIGAR vegan capsules are generally considered safe and are not known to have a significant impact on kidney function or renal failure patients. However, it’s important to note that individual responses to supplements can vary, especially in the context of renal failure.
February 24, 2024

The Role of Heparin in Cancer Treatment: Managing Venous Thromboembolism and Chemotherapy in Patients with Pancreatic Cancer

Heparin, available as both unfractionated and low-molecular-weight forms, has been extensively studied for its potential benefits in cancer patients. Low molecular weight heparin's role in both preventing and treating venous thromboembolism in patients, a common complication in cancer patients, has been the subject of systematic review and numerous randomized clinical trials. Furthermore, heparin has shown promising effects in managing VTE in patients undergoing cancer therapy, including those with advanced pancreatic cancer.
February 18, 2024

Prophylaxis of DVT in Pregnancy

Deep vein thrombosis (DVT) is a condition where blood clots form in the deep veins of the legs. During pregnancy, the risk of developing DVT increases because of changes in blood circulation and clotting factors. This is because the growing uterus can put pressure on the veins in the pelvis, slowing down blood flow from the legs and increasing the risk of clot formation.
February 12, 2024

Prophylactic Mitomycin-C Application for Haze Prevention after Photorefractive Keratectomy in Myopia: A Systematic Review

This systematic review explores the efficacy of prophylactic Mitomycin-C in preventing haze formation following Photorefractive Keratectomy for the treatment of myopia. The analysis compiles results from various studies to provide a comprehensive understanding of the effectiveness and safety of Mitomycin-C application in refractive surgery.
July 28, 2023

Vericiguat in Heart Failure Treatment

Vericiguat, a novel therapeutic approach, is making headway in the treatment of heart failure. Its unique mechanism of action, stimulating soluble guanylate cyclase (sGC), opens up new avenues in heart failure management. Clinical trials have shown promising results, indicating the potential for a significant improvement in patient outcomes. This post delves deeper into how Vericiguat is transforming the landscape of heart failure treatment.
July 1, 2023

Does genetics play a role in the development of diabetes mellitus?

Genetic factors indeed play a significant role in the development of diabetes mellitus. Both Type 1 and Type 2 diabetes have hereditary links, but they are influenced by different genetic and environmental factors. Our understanding of these genetic influences continues to grow, helping scientists develop more effective treatments and preventive measures.
Does genetics play a role in the development of diabetes mellitus?
This website uses cookies to improve your experience. By using this website you agree to our Cookie Policy.
Read more